TP53 and lung cancer: In this study, we found that estrogen-induced DNMT1 increased the DNA methylation of TP53 to repress p53 expression, which positively affected DNMT1 expression, thus promoting poor prognosis of lung cancer by modulating EMT and the microenvironment.